1 June 2022 - Canada on Wednesday authorised a single booster shot of Pfizer and partner BioNTech’s COVID-19 vaccine for ...
29 April 2022 - Moderna has asked Health Canada to approve its COVID-19 vaccine for children as young as six ...
20 April 2022 - Vertex has submitted this indication to CADTH & INESSS for health technology assessments. ...
28 March 2022 - Seqirus announced today that it has received Health Canada approval of Flucelvax Quad (influenza vaccine), its cell-based ...
28 March 2022 - This is the sixth indication for Dupixent in Canada, its second in asthma, and its second in ...
25 March 2022 - CNW/ - Vertex Pharmaceuticals Canada today announced that Health Canada has granted marketing authorisation for the ...
17 March 2022 - Announcement follows recent authorisation of the Company's mRNA COVID-19 vaccine in Australia and the European Union ...
17 November 2021 - Submission based on Phase 2/3 study of SPIKEVAX in children ages 6 to 11. ...
27 October 2021 - Vertex Pharmaceuticals today announced that its supplement to a new drug submission for Trikafta (elexacaftor/tezacaftor/ivacaftor and ...
18 October 2021 - Today, Health Canada received a submission from Pfizer-BioNTech seeking an authorisation for the use of its Comirnaty ...
22 September 2021 - Vertex Pharmaceuticals today announced its supplement to a new drug submission for Kalydeco (ivacaftor) has been ...
27 August 2021 - As the Delta variant rages through unvaccinated populations in Canada ahead of the back-to-school season, children ...
25 August 2021 - Vertex Pharmaceuticals was given approval to market its drug ivacaftor that treats children as young as ...
12 August 2021 - Blexten Label Expanded to Include Ages as Young as 4 Years Old. ...
7 June 2021 - Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 ...